| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5582061 | Clinical Lymphoma Myeloma and Leukemia | 2017 | 12 Pages |
Abstract
Results support existing registry data demonstrating that survival for HL has improved over the 4 decades analyzed. This data set is robust and validated, and it adds valuable understanding to the reasons behind the survival curves, which are a balance between efficacious therapies and decreased death related to cardiac conditions and second malignancies.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Amy Kwan, Nick Chadwick, Barry Hancock,